Plancorp LLC lowered its position in shares of Express Scripts Holding Company (NASDAQ:ESRX) by 7.3% during the second quarter, according to its most recent filing with the SEC. The fund owned 15,350 shares of the company’s stock after selling 1,210 shares during the period. Plancorp LLC’s holdings in Express Scripts Holding were worth $980,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of ESRX. Hancock Holding Co. boosted its stake in Express Scripts Holding by 9.9% in the first quarter. Hancock Holding Co. now owns 183,489 shares of the company’s stock worth $12,094,000 after buying an additional 16,536 shares in the last quarter. Van ECK Associates Corp boosted its stake in Express Scripts Holding by 28.8% in the first quarter. Van ECK Associates Corp now owns 373,636 shares of the company’s stock worth $24,626,000 after buying an additional 83,568 shares in the last quarter. Twin Capital Management Inc. boosted its stake in Express Scripts Holding by 0.8% in the first quarter. Twin Capital Management Inc. now owns 46,560 shares of the company’s stock worth $3,069,000 after buying an additional 360 shares in the last quarter. Wilkins Investment Counsel Inc. raised its position in shares of Express Scripts Holding by 6.9% in the first quarter. Wilkins Investment Counsel Inc. now owns 118,336 shares of the company’s stock worth $7,800,000 after buying an additional 7,630 shares during the last quarter. Finally, ACR Alpine Capital Research LLC raised its position in shares of Express Scripts Holding by 6.3% in the first quarter. ACR Alpine Capital Research LLC now owns 1,463,799 shares of the company’s stock worth $96,479,000 after buying an additional 87,292 shares during the last quarter. 90.24% of the stock is currently owned by institutional investors and hedge funds.

Shares of Express Scripts Holding Company (NASDAQ ESRX) traded up 0.29% during mid-day trading on Tuesday, reaching $61.49. 1,114,675 shares of the company’s stock traded hands. The stock has a market capitalization of $35.51 billion, a PE ratio of 10.67 and a beta of 0.90. The company’s 50-day moving average price is $62.62 and its 200-day moving average price is $64.34. Express Scripts Holding Company has a 12-month low of $57.80 and a 12-month high of $77.61.

Express Scripts Holding (NASDAQ:ESRX) last announced its quarterly earnings data on Tuesday, July 25th. The company reported $1.73 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.71 by $0.02. Express Scripts Holding had a net margin of 3.50% and a return on equity of 25.58%. The company had revenue of $25.35 billion during the quarter, compared to analysts’ expectations of $25.52 billion. During the same quarter in the prior year, the company earned $1.57 EPS. Express Scripts Holding’s revenue was up .5% compared to the same quarter last year. Analysts anticipate that Express Scripts Holding Company will post $6.99 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: “Express Scripts Holding Company (ESRX) Position Cut by Plancorp LLC” was originally posted by Watch List News and is owned by of Watch List News. If you are viewing this article on another publication, it was illegally stolen and republished in violation of United States and international copyright and trademark legislation. The correct version of this article can be read at https://www.watchlistnews.com/express-scripts-holding-company-esrx-position-cut-by-plancorp-llc/1491332.html.

ESRX has been the subject of a number of research analyst reports. SunTrust Banks, Inc. restated a “buy” rating on shares of Express Scripts Holding in a research report on Tuesday, April 25th. Jefferies Group LLC set a $88.00 price objective on Express Scripts Holding and gave the company a “buy” rating in a research report on Thursday, April 20th. UBS AG set a $71.00 price objective on Express Scripts Holding and gave the company a “hold” rating in a research report on Tuesday, April 25th. Edward Jones lowered Express Scripts Holding from a “buy” rating to a “hold” rating in a research report on Wednesday, April 26th. Finally, BidaskClub upgraded Express Scripts Holding from a “sell” rating to a “hold” rating in a research report on Saturday, June 17th. Four analysts have rated the stock with a sell rating, thirteen have given a hold rating, five have given a buy rating and one has given a strong buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus price target of $71.17.

In related news, VP Phyllis S. Anderson sold 1,100 shares of the company’s stock in a transaction dated Friday, May 19th. The shares were sold at an average price of $60.08, for a total transaction of $66,088.00. Following the completion of the sale, the vice president now owns 11,108 shares of the company’s stock, valued at approximately $667,368.64. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 0.68% of the stock is currently owned by corporate insiders.

About Express Scripts Holding

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Company (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts Holding (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with Analyst Ratings Network's FREE daily email newsletter.